A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation

FASEB Journal

Volumn 25, Issue 7, 2011, Pages 2201-2210

  Lecosnier, Sabine ^a,b   Cordier, Céline ^a,b   Simon, Philippe ^a,b   François, Jean Christophe ^a,b   Saison Behmoaras, Tula E ^a,b  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b INSERM   (France)

Author keywords

IGF signaling; Peptide nucleic acid; Prostate cancer; Triplex structure

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOMER; PEPTIDE NUCLEIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PURINE; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL TRANSFORMATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TRANSLATION REGULATION;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELL-FREE SYSTEM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEPTIDE NUCLEIC ACIDS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-AKT; PURINES; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 79960175861     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-169540     Document Type: Article

References (52)

1. Adams, T. E., Epa, V. C., Garrett, T. P., and Ward, C. W. (2000) Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 57, 1050-1093
2. Steller, M. A., Delgado, C. H., Bartels, C. J., Woodworth, C. D., and Zou, Z. (1996) Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Cancer Res. 56, 1761-1765 (Pubitemid 26118210)
3. Hellawell, G. O., Turner, G. D., Davies, D. R., Poulsom, R., Brewster, S. F., and Macaulay, V. M. (2002) Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res. 62, 2942-2950
4. Resnik, J. L., Reichart, D. B., Huey, K., Webster, N. J., and Seely, B. L. (1998) Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res. 58, 1159-1164
5. Kwon, J., Stephan, S., Mukhopadhyay, A., Muders, M. H., Dutta, S. K., Lau, J. S., and Mukhopadhyay, D. (2009) Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta. Cancer Res. 69, 1350-1357
6. Dallas, N. A., Xia, L., Fan, F., Gray, M. J., Gaur, P., van Buren, G., 2nd, Samuel, S., Kim, M. P., Lim, S. J., and Ellis, L. M. (2009) Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 69, 1951-1957
7. Sachdev, D., Li, S. L., Hartell, J. S., Fujita-Yamaguchi, Y., Miller, J. S., and Yee, D. (2003) A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Cancer Res. 63, 627-635 (Pubitemid 36158140)
8. Garcia-Echeverria, C., Pearson, M. A., Marti, A., Meyer, T., Mestan, J., Zimmermann, J., Gao, J., Brueggen, J., Capraro, H. G., Cozens, R., Evans, D. B., Fabbro, D., Furet, P., Porta, D. G., Liebetanz, J., Martiny-Baron, G., Ruetz, S., and Hofmann, F. (2004) In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5, 231-239 (Pubitemid 38402115)
9. Ji, Q. S., Mulvihill, M. J., Rosenfeld-Franklin, M., Cooke, A., Feng, L., Mak, G., O'Connor, M., Yao, Y., Pirritt, C., Buck, E., Eyzaguirre, A., Arnold, L. D., Gibson, N. W., and Pachter, J. A. (2007) A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo. Mol. Cancer Ther. 6, 2158-2167
10. Moser, C., Schachtschneider, P., Lang, S. A., Gaumann, A., Mori, A., Zimmermann, J., Schlitt, H. J., Geissler, E. K., and Stoeltzing, O. (2008) Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. Eur. J. Cancer 44, 1577-1586
11. Chernicky, C. L., Tan, H., Yi, L., Loret de Mola, J. R., and Ilan, J. (2002) Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo. Mol. Pathol. 55, 102-109
12. D'Cunja, J., Shalaby, T., Rivera, P., von Buren, A., Patti, R., Heppner, F. L., Arcaro, A., Rorke-Adams, L. B., Phillips, P. C., and Grotzer, M. A. (2007) Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells. Eur. J. Cancer 43, 1581-1589
13. Furukawa, J., Wraight, C. J., Freier, S. M., Peralta, E., Atley, L. M., Monia, B. P., Gleave, M. E., and Cox, M. E. (2010) Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer. Prostate 70, 206-218
14. Rochester, M. A., Riedemann, J., Hellawell, G. O., Brewster, S. F., and Macaulay, V. M. (2005) Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Ther. 12, 90-100
15. Zhang, H., Pelzer, A. M., Kiang, D. T., and Yee, D. (2007) Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Cancer Res. 67, 391-397 (Pubitemid 46142798)
16. Oussedik, K., Francois, J. C., Halby, L., Senamaud-Beaufort, C., Toutirais, G., Dallavalle, S., Pommier, Y., Pisano, C., and Arimondo, P. B. (2010) Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecins. FASEB J. 24, 2235-2244
17. Francois, J. C., Lacoste, J., Lacroix, L., and Mergny, J. L. (2000) Design of antisense and triplex-forming oligonucleotides. Methods Enzymol. 313, 74-95
18. Min, Y., Adachi, Y., Yamamoto, H., Ito, H., Itoh, F., Lee, C. T., Nadaf, S., Carbone, D. P., and Imai, K. (2003) Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer. Cancer Res. 63, 6432-6441 (Pubitemid 37255193)
19. Reinmuth, N., Fan, F., Liu, W., Parikh, A. A., Stoeltzing, O., Jung, Y. D., Bucana, C. D., Radinsky, R., Gallick, G. E., and Ellis, L. M. (2002) Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon. Cancer Lab. Invest. 82, 1377-1389
20. Reiss, K., D'Ambrosio, C., Tu, X., Tu, C., and Baserga, R. (1998) Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res. 4, 2647-2655 (Pubitemid 28523490)
21. Gualberto, A., and Pollak, M. (2009) Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions. Oncogene 28, 3009-3021
22. Jackson, A. L., and Linsley, P. S. (2004) Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 20, 521-524 (Pubitemid 39314555)
23. Sazani, P., Gemignani, F., Kang, S. H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D., and Kole, R. (2002) Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20, 1228-1233 (Pubitemid 35462487)
24. Yin, H., Betts, C., Saleh, A. F., Ivanova, G. D., Lee, H., Seow, Y., Kim, D., Gait, M. J., and Wood, M. J. (2010) Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. Mol. Ther. 18, 819-827
25. Baker, B. F., Lot, S. S., Condon, T. P., Cheng-Flournoy, S., Lesnik, E. A., Sasmor, H. M., and Bennett, C. F. (1997) 2′-O-(2-Methoxy)ethyl- modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 272, 11994-12000
26. Boudvillain, M., Guerin, M., Dalbies, R., Saison-Behmoaras, T., and Leng, M. (1997) Transplatin-modified oligo(2′-O-methyl ribonucleotide)s: a new tool for selective modulation of gene expression. Biochemistry 36, 2925-2931 (Pubitemid 27138576)
27. Gee, J. E., Robbins, I., van der Laan, A. C., van Boom, J. H., Colombier, C., Leng, M., Raible, A. M., Nelson, J. S., and Lebleu, B. (1998) Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 8, 103-111 (Pubitemid 28223329)
28. Boutimah-Hamoudi, F., Leforestier, E., Senamaud-Beaufort, C., Nielsen, P. E., Giovannangeli, C., and Saison-Behmoaras, T. E. (2007) Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA. Nucleic Acids Res. 35, 3907-3917
29. Dias, N., Senamaud-Beaufort, C., Forestier El, E., Auvin, C., Helene, C., and Ester Saison-Behmoaras, T. (2002) RNA hairpin invasion and ribosome elongation arrest by mixed base PNA oligomer. J. Mol. Biol. 320, 489-501 (Pubitemid 34753976)
30. Knudsen, H., and Nielsen, P. E. (1996) Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res. 24, 494-500
31. Senamaud-Beaufort, C., Leforestier, E., and Saison-Behmoaras, T. E. (2003) Short pyrimidine stretches containing mixed base PNAs are versatile tools to induce translation elongation arrest and truncated protein synthesis. Oligonucleotides 13, 465-478
32. Mayfield, L. D., and Corey, D. R. (1999) Automated synthesis of peptide nucleic acids and peptide nucleic acid-peptide conjugates. Anal. Biochem. 268, 401-404
33. Faria, M., Spiller, D. G., Dubertret, C., Nelson, J. S., White, M. R., Scherman, D., Helene, C., and Giovannangeli, C. (2001) Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo. Nat. Biotechnol. 19, 40-44 (Pubitemid 32051954)
34. Wu, B., Moulton, H. M., Iversen, P. L., Jiang, J., Li, J., Spurney, C. F., Sali, A., Guerron, A. D., Nagaraju, K., Doran, T., Lu, P., Xiao, X., and Lu, Q. L. (2008) Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc. Natl. Acad. Sci. U. S. A. 105, 14814-14819
35. Roberts, J., Palma, E., Sazani, P., Orum, H., Cho, M., and Kole, R. (2006) Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice. Mol. Ther. 14, 471-475 (Pubitemid 44296096)
36. Nulf, C. J., and Corey, D. (2004) Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs). Nucleic Acids Res. 32, 3792-3798 (Pubitemid 39199071)
37. Vester, B., and Wengel, J. (2004) LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 43, 13233-13241 (Pubitemid 39391124)
38. Nickerson, T., Chang, F., Lorimer, D., Smeekens, S. P., Sawyers, C. L., and Pollak, M. (2001) In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res. 61, 6276-6280 (Pubitemid 32762567)
39. Burfeind, P., Chernicky, C. L., Rininsland, F., and Ilan, J. (1996) Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 93, 7263-7268 (Pubitemid 26243537)
40. Rogers, F. A., Vasquez, K. M., Egholm, M., and Glazer, P. M. (2002) Site-directed recombination via bifunctional PNA-DNA conjugates. Proc. Natl. Acad. Sci. U. S. A. 99, 16695-16700
41. Shyu, A. B., Wilkinson, M. F., and van Hoof, A. (2008) Messenger RNA regulation: to translate or to degrade. EMBO J. 27, 471-481 (Pubitemid 351225677)
42. Valentinis, B., and Baserga, R. (2001) IGF-I receptor signalling in transformation and differentiation. Mol. Pathol. 54, 133-137 (Pubitemid 32539602)
43. Reynolds, A., Anderson, E. M., Vermeulen, A., Fedorov, Y., Robinson, K., Leake, D., Karpilow, J., Marshall, W. S., and Khvorova, A. (2006) Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12, 988-993 (Pubitemid 43788117)
44. Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., Endres, S., and Hartmann, G. (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263-270 (Pubitemid 40460553)
45. Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., Marshall, W., Khvorova, A., and Linsley, P. S. (2006) Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA 12, 1197-1205
46. Crooke, S. T., Lemonidis, K. M., Neilson, L., Griffey, R., Lesnik, E. A., and Monia, B. P. (1995) Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide RNA duplexes. Biochem. J. 312, 599-608 (Pubitemid 26002231)
47. Nielsen, P. E. (2002) PNA technology. Methods Mol. Biol. 208, 3-26
48. Dias, N., Dheur, S., Nielsen, P. E., Gryaznov, S., Van Aerschot, A., Herdewijn, P., Helene, C., and Saison-Behmoaras, T. E. (1999) Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J. Mol. Biol. 294, 403-416
49. Armitage, B. A. (2003) The impact of nucleic acid secondary structure on PNA hybridization. Drug Discov. Today 8, 222-228
50. Bendifallah, N., Rasmussen, F. W., Zachar, V., Ebbesen, P., Nielsen, P. E., and Koppelhus, U. (2006) Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjug. Chem. 17, 750-758 (Pubitemid 43794386)
51. Shiraishi, T., Hamzavi, R., and Nielsen, P. E. (2008) Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells. Nucleic Acids Res. 36, 4424-4432
52. Egholm, M., Christensen, L., Dueholm, K. L., Buchardt, O., Coull, J., and Nielsen, P. E. (1995) Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Res. 23, 217-222